If so.... read on.
http://www.fda.gov/ohrms/dockets/98fr/090800c.htmSUMMARY: The Food and Drug Administration (FDA) is authorizing the use,
on food labels and in food labeling, of health claims on the
association between plant sterol/stanol esters and reduced risk of
coronary heart disease (CHD). FDA is taking this action in response to
a petition filed by Lipton (plant sterol esters petitioner) and a
petition filed by McNeil Consumer Healthcare (plant stanol esters
petitioner). Based on the totality of publicly available evidence, the
agency has concluded that plant sterol/stanol esters may reduce the
risk of CHD.
DATES: This rule is effective September 8, 2000. Submit written
comments by November 22, 2000. The Director of the Office of the
Federal Register approves the incorporation by reference in accordance
with 5 U.S.C. 552(a) and 1 CFR part 51 of certain publications in 21
CFR 101.83(c)(2)(ii)(A)(2) and (c)(2)(ii)(B)(2), as of September 8,
2000.
ADDRESSES: Submit written comments to the Dockets Management Branch
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Sharon A. Ross, Center for Food Safety
and Applied Nutrition (HFS-832), Food and Drug Administration, 200 C
St. SW., Washington, DC 20204, 202-205-5343.